Literature DB >> 9865717

Overexpression of the tumor suppressor gene Smad4/DPC4 induces p21waf1 expression and growth inhibition in human carcinoma cells.

K K Hunt1, J B Fleming, A Abramian, L Zhang, D B Evans, P J Chiao.   

Abstract

The Smad4/DPC4 protein functions as a key transcription factor in transforming growth factor beta (TGF-beta) signaling pathways. However, the downstream target genes regulated by Smad4/DPC4 have not been identified until now. We previously demonstrated that the loss of TGF-beta-induced p21waf1 expression and growth inhibition correlates with inactivation of the Smad4/DPC4 gene. Now we show that transient overexpression of Smad4/DPC4 can induce p21waf1 expression, specific Smad4 DNA binding activity, SBE4-luc reporter gene activity, and subsequent growth inhibition in Smad4/DPC4-null cells and other carcinoma cells in the presence or absence of TGF-beta. Taken together, these data show that p21waf1 is one of the Smad4/DPC4-regulated downstream target genes and suggest that overexpression of the Smad4/DPC4 gene can bypass TGF-beta receptor activation and reestablish one of the key regulatory controls of cell proliferation.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9865717

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  10 in total

1.  Insights Into SMAD4 Loss in Pancreatic Cancer From Inducible Restoration of TGF-β Signaling.

Authors:  Paul T Fullerton; Chad J Creighton; Martin M Matzuk
Journal:  Mol Endocrinol       Date:  2015-08-18

2.  NF-kappaB and AP-1 connection: mechanism of NF-kappaB-dependent regulation of AP-1 activity.

Authors:  Shuichi Fujioka; Jiangong Niu; Christian Schmidt; Guido M Sclabas; Bailu Peng; Tadashi Uwagawa; Zhongkui Li; Douglas B Evans; James L Abbruzzese; Paul J Chiao
Journal:  Mol Cell Biol       Date:  2004-09       Impact factor: 4.272

Review 3.  A clinically relevant model of human pancreatic adenocarcinoma identifies patterns of metastasis associated with alterations of the TGF-beta/Smad4 signaling pathway.

Authors:  Shane Holloway; Mishel Davis; Raffat Jaber; Jason Fleming
Journal:  Int J Gastrointest Cancer       Date:  2003

Review 4.  Transforming growth factor-beta and breast cancer: Cell cycle arrest by transforming growth factor-beta and its disruption in cancer.

Authors:  J Donovan; J Slingerland
Journal:  Breast Cancer Res       Date:  2000-02-21       Impact factor: 6.466

5.  Hepatitis B Virus X Protein Upregulates hELG1/ ATAD5 Expression through E2F1 in Hepatocellular Carcinoma.

Authors:  Alip Ghosh; Suchandrima Ghosh; Debanjali Dasgupta; Amit Ghosh; Somenath Datta; Nilabja Sikdar; Simanti Datta; Abhijit Chowdhury; Soma Banerjee
Journal:  Int J Biol Sci       Date:  2016-01-01       Impact factor: 6.580

6.  Smad4 suppresses the tumorigenesis and aggressiveness of neuroblastoma through repressing the expression of heparanase.

Authors:  Hongxia Qu; Liduan Zheng; Wanju Jiao; Hong Mei; Dan Li; Huajie Song; Erhu Fang; Xiaojing Wang; Shiwang Li; Kai Huang; Qiangsong Tong
Journal:  Sci Rep       Date:  2016-09-06       Impact factor: 4.379

7.  The Heparanase Inhibitor PG545 Attenuates Colon Cancer Initiation and Growth, Associating with Increased p21 Expression.

Authors:  Preeti Singh; Alexandra Blatt; Sari Feld; Yaniv Zohar; Esraa Saadi; Liza Barki-Harrington; Edward Hammond; Neta Ilan; Israel Vlodavsky; Yehuda Chowers; Elizabeth Half
Journal:  Neoplasia       Date:  2017-01-29       Impact factor: 5.715

8.  miRNA-558 promotes gastric cancer progression through attenuating Smad4-mediated repression of heparanase expression.

Authors:  Liduan Zheng; Wanju Jiao; Huajie Song; Hongxia Qu; Dan Li; Hong Mei; Yajun Chen; Feng Yang; Huanhuan Li; Kai Huang; Qiangsong Tong
Journal:  Cell Death Dis       Date:  2016-09-29       Impact factor: 8.469

Review 9.  The role of TGF-β/SMAD4 signaling in cancer.

Authors:  Ming Zhao; Lopa Mishra; Chu-Xia Deng
Journal:  Int J Biol Sci       Date:  2018-01-12       Impact factor: 6.580

Review 10.  CD36 and CD97 in Pancreatic Cancer versus Other Malignancies.

Authors:  Cristiana Tanase; Ancuta-Augustina Gheorghisan-Galateanu; Ionela Daniela Popescu; Simona Mihai; Elena Codrici; Radu Albulescu; Mihail Eugen Hinescu
Journal:  Int J Mol Sci       Date:  2020-08-06       Impact factor: 5.923

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.